HALO logo
halo search icon
Protagonist Therapeutics, Inc.
Protagonist Therapeutics, Inc.
PTGX · NAS

Protagonist Therapeutics, Inc.

US$102.01

Price Arrow1.13 (1.12%)
21/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusEngulfing Bearish (Realtime)HALO AllHALO Balance SheetHALO Earnings MomentumHALO GARPHALO Growth+4
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Protagonist Therapeutics, Inc. Overview

PTGX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Strong

Garp

Very Strong

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Neutral

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Weak

Quality

Capital Efficiency

Neutral

Balance Sheet

Very Strong

About PTGX

icon

Telephone

1.510.474.0170

icon

Address

Suite 140, 7707 Gateway Boulevard, Newark, CA 94560-1160

Description

Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943. The company was founded by Mark L. Smythe on August 22, 2006 and is headquartered in Newark, CA.

PTGX Price Chart

Key Stats

Market Cap

US$6.49B

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 45.05 - 107.84

Trade Value (12mth)

US$17,100,658.00

1 week

-1.27%

1 month

-4.42%

YTD

15.71%

1 year

119.73%

All time high

107.84

Key Fundamentals

EPS 3 yr Growth

-21.20%

EBITDA Margin

-341.00%

Operating Cashflow

$58m

Free Cash Flow Return

8.80%

ROIC

-19.90%

Interest Coverage

0.00

Quick Ratio

12.70

Other Data

Shares Outstanding (Fully Diluted)

70m

HALO Sector

Healthcare

Next Company Report Date

02-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

PTGX Announcements

Latest Announcements

DateAnnouncements
06 May 26
06 May 26
06 May 26
06 May 26
26 February 26

PTGX Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-1.394.47-2.05locklocklock
EPS (Fully Diluted)
$locklocklocklock-1.394.23-2.05locklocklock
Growth
%locklocklocklock46.5421.4-145.8locklocklock
PE
XlocklocklocklockN/A9.1N/Alocklocklock
EV/EBITDA
XlocklocklocklockN/A8.2N/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Protagonist Therapeutics, Inc. (PTGX:NAS)?
Halo FAQ
The current share price of Protagonist Therapeutics, Inc. (PTGX:NAS) is USD$102.01.
What is the 52-week high share price for Protagonist Therapeutics, Inc. (PTGX:NAS)?
Halo FAQ
The 52-week high share price for Protagonist Therapeutics, Inc. (PTGX:NAS) is USD$107.84.
What is the 52-week low share price for Protagonist Therapeutics, Inc. (PTGX:NAS)?
Halo FAQ
The 52-week low share price for Protagonist Therapeutics, Inc. (PTGX:NAS) is USD$45.05.
What is the dividend yield for Protagonist Therapeutics, Inc. (PTGX:NAS)?
Halo FAQ
Protagonist Therapeutics, Inc. (PTGX:NAS) does not pay a dividend.
What was Protagonist Therapeutics, Inc. (PTGX:NAS) last dividend payment?
Halo FAQ
Protagonist Therapeutics, Inc. (PTGX:NAS) does not pay a dividend.
What is the franking level for Protagonist Therapeutics, Inc. (PTGX:NAS)?
Halo FAQ
Protagonist Therapeutics, Inc. (PTGX:NAS) has a franking level of 0.00%.
In which sector is Protagonist Therapeutics, Inc. (PTGX:NAS) classified?
Halo FAQ
Protagonist Therapeutics, Inc. (PTGX:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.